Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Myomo, Inc. before investing.

In this article, we go over a few key elements for understanding Myomo, Inc.’s stock price such as:

• Myomo, Inc.’s current stock price and volume
• Why Myomo, Inc.’s stock price changed recently
• Upgrades and downgrades for MYO from analysts
• MYO’s stock price momentum as measured by its relative strength

About Myomo, Inc. (MYO)

Before we jump into Myomo, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Want to learn more about Myomo, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Myomo, Inc..

Myomo, Inc.’s Stock Price as of Market Close

As of March 31, 2026, 4:00 PM, CST, Myomo, Inc.’s stock price was $0.676.

Myomo, Inc. is up 5.55% from its previous closing price of $0.640.

During the last market session, Myomo, Inc.’s stock traded between $0.605 and $0.690. Currently, there are approximately 42.21 million shares outstanding for Myomo, Inc..

Myomo, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Myomo, Inc. Stock Price History

Myomo, Inc.’s (MYO) price is currently down 12.83% so far this month.

During the month of March, Myomo, Inc.’s stock price has reached a high of $0.850 and a low of $0.605.

Over the last year, Myomo, Inc. has hit prices as high as $5.037 and as low as $0.605. Year to date, Myomo, Inc.’s stock is down 25.76%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Myomo, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 31, 2026, there was 1 analyst who downgraded Myomo, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Myomo, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Myomo, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Myomo, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Myomo, Inc. (MYO) by visiting AAII Stock Evaluator.

Relative Price Strength of Myomo, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 31, 2026, Myomo, Inc. has a weighted four-quarter relative price strength of -33.20%, which translates to a Momentum Score of 4 and is considered to be Very Weak.

Want to learn more about how Myomo, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Myomo, Inc. Stock Price: Bottom Line

As of March 31, 2026, Myomo, Inc.’s stock price is $0.676, which is up 5.55% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Myomo, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.